Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 2/20 | 0.35 |
| ▸ | MAT2A | P31153 | 1/20 | 0.33 |
| ▸ | TACR1 | P25103 | 2/20 | 0.31 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRG | P48443 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.31 |
| ▸ | XDH | P47989 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19903510 | 0.95 | PTGER4 (0.36) | PTGER4MAT2ATACR1GPBAR1RXRA | |
| SCHEMBL20616996 | 0.95 | PTGER4 (0.36) | PTGER4MAT2ATACR1GPBAR1RXRA | |
| SCHEMBL19912514 | 0.95 | TACR1 (0.31) | PTGER4MAT2ATACR1GPBAR1RXRA | |
| SCHEMBL19912518 | 0.93 | CYP1A2 (0.34) | PTGER4MAT2ATACR1RXRARXRG | |
| SCHEMBL20616824 | 0.91 | CTSS (0.37) | PTGER4MAT2AMEN1ALDH1A1CYP1A2 | |
| SCHEMBL22822256 | 0.91 | RXRA (0.37) | MAT2AGPBAR1RXRARXRGXDH | |
| SCHEMBL19912513 | 0.91 | RXRA (0.35) | MAT2AGPBAR1RXRARXRGXDH | |
| SCHEMBL20616998 | 0.90 | RXRA (0.34) | PTGER4MAT2ATACR1GPBAR1RXRA | |
| SCHEMBL19903517 | 0.90 | KIF11 (0.33) | PTGER4MAT2ATACR1GPBAR1RXRA | |
| SCHEMBL19912515 | 0.90 | RXRA (0.33) | MAT2AGPBAR1RXRARXRGXDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180062086-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, AOC3 | PTGER4 993/4885MAT2A 2653/4885TACR1 1242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.